Showing results (41-50 of 82) with videos related to
Sort By:
Pageof 9
Blood|April 20, 2002
Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular eventsScott R Dobson, Kenton R Holden, Paul J Nietert, et al.Cancer Medicine|July 31, 2025
Outcome and Challenges in the Treatment of Pediatric Hodgkin Lymphoma With Euronet-PHL-C1 Protocol: Experience From a Resource-Limited CountryElie Bechara, Toufic Eid, Arwa El-Dhuwaib, et al.Ecancermedicalscience|October 18, 2024
Parents providing palliative care for children with cancerRima Saad Rassam, Huda Abu-Saad Huijer, Samar Noureddine, et al.Pediatric Blood & Cancer|June 8, 2023
Unfolding parental knowledge, attitudes, and beliefs toward palliative care for children with cancerRima Saad Rassam, Huda Abu-Saad Huijer, Samar Noureddine, et al.Haematologica|December 19, 2025
Left ventricular strain and chamber dimensions in pediatric sickle cell disease: agerelated reduction in myocardial deformation independent of hemolysis and hydroxyurea therapyZiad Bulbul, Rana Zareef, Tania Abi Nassif, et al.Hemoglobin|October 2, 2014
Priapism, an emerging complication in β-thalassemia intermedia patientsNaji S Mallat, David Wehbe, Anthony Haddad, et al.Pediatric Blood & Cancer|March 18, 2006
Primary malignant peripheral nerve sheath tumor of the lung in a young child without neurofibromatosis type 1Samar A Muwakkit, Carlos Rodriguez-Galindo, Ahmad I El Samra, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 23, 2009
Renal venous thrombosis in a newborn with prothrombotic risk factorsSamar A Muwakkit, Raya Saab, Sami A Sanjad, et al.Pediatric Blood & Cancer|September 12, 2022
Heritable cancer predisposition testing in pediatric cancer patients excluding retinoblastoma in a middle-income countryOmar El Khatib, Yasser Yahya, Rami Mahfouz, et al.Contemporary Clinical Trials|August 26, 2019
Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3)Matthew M Heeney, Miguel R Abboud, Carl Amilon, et al.Pageof 9